2024 2024 2026 In this meta-analysis of 12 randomized clinical trials testing the effects of ivermectin as a treatment for COVID-19, favorable mortality results were … Significantly improved recovery and significantly lower risk of long COVID with ivermectin, despite very late treatment, low-risk patients, and poor … 2022 2025 Ivermectin was recently suggested as a possible COVID-19 therapy, yet its clinical efficacy and safety remain controversial. This meta-analysis … Ivermectin treats or prevents certain parasite infections in animals and in humans. These drugs don\’t treat viruses. Taking large doses of this … 2021 2025 2025 2023 2023 2023 2022 2024 In six randomized trials of moderate or severe infection, there was a 75% reduction in mortality (Relative Risk=0.25 [95%CI 0.12-0.52]; p=0.0002); … 2022 2021 2023 (June 2023). \”Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials\”. 2024 The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on … 2023 Conclusions In comparison to SOC or placebo, IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 … New Study Evaluates High Dose Ivermectin, Fluvoxamine, and Metformin for Outpatient COVID-19. MedCram – Medical Lectures Explained CLEARLY … 2023 Conclusions: In non-hospitalized COVID-19 patients, ivermectin did not have effect on clinical, non- clinical or safety outcomes versus controls …